A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding

As SARS-CoV-2 continues to spread around the world, there is an urgent need for new assay formats to characterize the humoral response to infection. Convalescent serum is being used for treatment and for isolation of patient-derived antibodies. However, currently there is not a simple means to estim...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:medRxiv
Autores principales: Byrnes, James R., Zhou, Xin X., Lui, Irene, Elledge, Susanna K., Glasgow, Jeff E., Lim, Shion A., Loudermilk, Rita, Chiu, Charles Y., Wilson, Michael R., Leung, Kevin K., Wells, James A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273274/
https://ncbi.nlm.nih.gov/pubmed/32511506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.27.20114652
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares